296 related articles for article (PubMed ID: 25807822)
1. [Nucleotide receptors--structure and function, history and perspectives].
Barańska J
Postepy Biochem; 2014; 60(4):424-37. PubMed ID: 25807822
[TBL] [Abstract][Full Text] [Related]
2. Purine and pyrimidine receptors.
Burnstock G
Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
[TBL] [Abstract][Full Text] [Related]
3. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast responses to nucleotides increase during differentiation.
Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
[TBL] [Abstract][Full Text] [Related]
5. Presynaptic adenosine and P2Y receptors.
Gonçalves J; Queiroz G
Handb Exp Pharmacol; 2008; (184):339-72. PubMed ID: 18064419
[TBL] [Abstract][Full Text] [Related]
6. Multiple P2Y receptors couple to calcium-dependent, chloride channels in smooth muscle cells of the rat pulmonary artery.
Chootip K; Gurney AM; Kennedy C
Respir Res; 2005 Oct; 6(1):124. PubMed ID: 16250909
[TBL] [Abstract][Full Text] [Related]
7. Cloning and functional characterization of two murine uridine nucleotide receptors reveal a potential target for correcting ion transport deficiency in cystic fibrosis gallbladder.
Lazarowski ER; Rochelle LG; O'Neal WK; Ribeiro CM; Grubb BR; Zhang V; Harden TK; Boucher RC
J Pharmacol Exp Ther; 2001 Apr; 297(1):43-9. PubMed ID: 11259526
[TBL] [Abstract][Full Text] [Related]
8. Overview of the P2 receptors.
Boeynaems JM; Communi D; Gonzalez NS; Robaye B
Semin Thromb Hemost; 2005 Apr; 31(2):139-49. PubMed ID: 15852217
[TBL] [Abstract][Full Text] [Related]
9. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
10. P2Y receptors: focus on structural, pharmacological and functional aspects in the brain.
Fischer W; Krügel U
Curr Med Chem; 2007; 14(23):2429-55. PubMed ID: 17979698
[TBL] [Abstract][Full Text] [Related]
11. Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.
Sabala P; Czajkowski R; Przybyłek K; Kalita K; Kaczmarek L; Barańska J
Br J Pharmacol; 2001 Jan; 132(2):393-402. PubMed ID: 11159687
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP-induced calcium signaling in mIMCD-3 cells requires both P2X and P2Y purinoceptors.
Xia SL; Wang L; Cash MN; Teng X; Schwalbe RA; Wingo CS
Am J Physiol Renal Physiol; 2004 Aug; 287(2):F204-14. PubMed ID: 15068972
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors.
King BF; Townsend-Nicholson A; Burnstock G
Trends Pharmacol Sci; 1998 Dec; 19(12):506-14. PubMed ID: 9871413
[TBL] [Abstract][Full Text] [Related]
14. The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors.
Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Volpini R; Cristalli G
Curr Med Chem; 2011; 18(10):1444-63. PubMed ID: 21428896
[TBL] [Abstract][Full Text] [Related]
15. Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors.
Koizumi S; Ohsawa K; Inoue K; Kohsaka S
Glia; 2013 Jan; 61(1):47-54. PubMed ID: 22674620
[TBL] [Abstract][Full Text] [Related]
16. P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.
Woods LT; Forti KM; Shanbhag VC; Camden JM; Weisman GA
Biochem Pharmacol; 2021 May; 187():114406. PubMed ID: 33412103
[TBL] [Abstract][Full Text] [Related]
17. Control of epithelial transport via luminal P2 receptors.
Leipziger J
Am J Physiol Renal Physiol; 2003 Mar; 284(3):F419-32. PubMed ID: 12556361
[TBL] [Abstract][Full Text] [Related]
18. The past, present and future of purine nucleotides as signalling molecules.
Burnstock G
Neuropharmacology; 1997 Sep; 36(9):1127-39. PubMed ID: 9364468
[No Abstract] [Full Text] [Related]
19. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
